scientific article; zbMATH DE number 3856244
[For the entire collection see Zbl 0517.00012.] Given N patients alloted in n pairs to one of two treatments, the authors consider stopping rules for n which minimize the expected number of patients on the inferior treatment. When the outcome (difference between treatments in a pair) is normal, a class of asymptotically optimal rates are produced. If \(t=n/N\) these rules have stopping behaviour of the form f(t)\(\sim(2t \log t^{-1})^{1/2}\) as \(t\to 0\), and there exist \(\eta<3/2\) and \(t_ 0>0\) such that \[ f(t)\geq \{2t(\log t^{-1}-\eta \log \log t^{-1})\}^{1/2}\quad for\quad all\quad 0<t<t_ 0. \]
- Asymptotic efficiency of a seqrential allocation rule
- Bayes rules for a clinical-trials model with dichotomous responses
- On the Allocation of Treatments in Sequential Medical Trials
- Optimal adaptive designs for binary response trials
- Two-stage selection and testing designs for comparative clinical trials
- Bayes rules for a clinical-trials model with dichotomous responses
- An O'Brien-Fleming sequential trial for comparing three treatments
- Optimal stopping for Brownian motion with applications to sequential analysis and option pricing
- Comparing exponential clinical trials by combining individual sequential experiments available from independent studies
- An efficient sequential design of clinical trials
- Sequential methods for comparative effectiveness experiments: point of care clinical trials
- Construction of an Optimal Sequential Plan for Testing a Treatment for an Adverse Effect
- Sequential Designs in Bioassay
- Sequential allocation in clinical trials
- Fixed and sequential treatment allocation in clinical trials
- A Sequential Test for Comparing Two Infection Rates in a Randomized Clinical Trial, and Incorporation of Data Accumulated after Stopping
- Two-stage selection and testing designs for comparative clinical trials
- Truncated sequential medical trials involving paired data
- Asymptotic efficiency of a seqrential allocation rule
- Some tests for differences between proportions where the expected number of exposures to an inferior treatment is kept small
- Anscombe's model for sequential clinical trials revisited
- Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities
- Incorporating scientific, ethical and economic considerations into the design of clinical trials in the pharmaceutical industry: a sequential approach
- Retrospective Analysis of Sequential Dose‐Finding Designs
- Nonparametric bandit methods
This page was built for publication:
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3324874)